Person: KIRPINAR, İSMET
Now showing 1 - 10 of 114
- PublicationMetadata onlyDry Eye Related to Commonly Used New Antidepressants(2015-01-01) KOÇER, Emel; KOÇER, Abdulkadir; ÖZSÜTÇÜ, Mustafa; DURSUN, Ali Emre; KIRPINAR, İSMET; KIRPINAR, İSMET
- PublicationMetadata onlyBupropion induced Hyperprolactonamia: A case report. Bulletin of Clinical Psychopharmacology(2015-04-19) KIRPINAR, İSMET; Kılıç, Alperen; Öztürk, AHMET; KIRPINAR, İSMET; ÖZTÜRK, AHMET
- PublicationMetadata onlyYaşlı Hastalarda Bilişsel Bozulma İle Ajitasyon Arasındaki İlişki(2014-11-16) BOYRAZ, RABİA KEVSER; KIRPINAR, İSMET; DEVECİ, ERDEM; BOYRAZ, RABIA KEVSER; KIRPINAR, İSMET; DEVECİ, ERDEM
- PublicationOpen AccessCOVID-19 Pandemic: Stress and Psychiatric Disorders(2021-02-01T00:00:00Z) KIRPINAR, İSMET; KIRPINAR, İSMETThe epidemic, which first started as viral pneumonia in Wuhan, China at the end of 2019 and is now known as Coronavirus disease-19 (COVID-19). rapidly spread to almost every part of the world and named a pandemic in March 2020. It is well known that psychiatric symptoms and syndromes, especially posttraumatic stress disorder, major depression, anxiety, and sleep disorders reach high prevalence values in natural or man-made disasters, Especially in infectious disease epidemics where mortality rates are high, patients, those who arc quarantined, and the whole society experience very intense mental stress and trauma. It is not easy to avoid psychological distress after facing highly fatal illnesses such as Ebola, severe acute respiratory syndrome (SARS), or COVID-19. When pandemics turn into a rapid and global disaster, the prevalence values of mental problems reach even higher levels. Combating mental disorders not only provides psychological well-being but also affects the course of the epidemic, as these disorders can delay efforts to fight epidemics.
- PublicationMetadata onlyPSYCHOTIC EXACERBATIONS IN A PATIENT WITH MULTIPLE SCLEROSIS(2010-01-01T00:00:00Z) YAZICI, A. B.; Yazici, E.; Kirpinar, I.; KIRPINAR, İSMET
- PublicationMetadata onlyDepersonalization Associated with Kallman s Syndrome a Case Report(2015-04-19) ÖZTÜRK, AHMET; KILIÇ, ALPEREN; DURSUN, ALİ EMRE; DEVECİ, ERDEM; KIRPINAR, İSMET; ÖZTÜRK, AHMET; DEVECİ, ERDEM; KIRPINAR, İSMET
- PublicationMetadata onlyDown syndrome and dementia: Relationship and clinical features Down Sendromu ve Demans: İlişkisi ve Klinik Özellikleri(2016-01-01) GORMEZ, Aynur; KIRPINAR, İSMET; KIRPINAR, İSMET
- PublicationMetadata onlyPredictors of long-term anxiety and depression in discharged COVID-19 patients: A follow-up study(2022-08-01T00:00:00Z) Boyraz, Rabia Kevser; Şahan, Ebru; Boylu, Muhammed Emin; Kırpınar, İsmet; BOYLU, MUHAMMED EMİN; KIRPINAR, İSMET
- PublicationMetadata onlyGeriatri Pratiğinde İlaç Tedavisi(2015-05-01) KIRPINAR, İSMET; KIRPINAR, İSMET
- PublicationMetadata onlyThe psychiatric assessment schedule for adults with developmental disability checklist: reliability and validity of Turkish version(2017-01-01) GORMEZ, Aynur; Kirpinar, Ismet; KIRPINAR, İSMETAim/background: There is a lack of psychometric instruments to measure psychopathology in people with intellectual disabilities (ID). This may lead to underdiagnosis of treatable psychiatric comorbidities in this population. Psychiatric assessment schedule for adults with developmental disabilities (PAS-ADD) Checklist was developed as a screening tool designed for lay people. The PAS-ADD Checklist was created in English and was later on validated for other languages, including French and German. There is no psychometric measure available in Turkish to screen for or detect psychiatric symptoms in adults with ID. The aim of the present study was to present a psychometric evidence of the Turkish language version of the PAS-ADD Checklist. This is the first study aiming to present and validate a psychiatric screening instrument for adults with ID in Turkey.